›› 2011, Vol. 10 ›› Issue (7): 365-367.doi: 10.3969/j.issn.1671-4091.2011.07.00

• 临床研究 • Previous Articles     Next Articles

The influence of maintenance hemodialysis on the expression of inflammatory marker lipoprotein-associated phospholipase A2 in end stage renal disease patients

LIU Yang, JIN Lv-ying, LI Li, DU Jing-tao   

  1. 1Department of Nephrology, Yichang Central People’s Hospital, the First College of Clinical Medical Science, China Three Gorges University, Yichang 443003, China; 2Research Institute of Cardiovascular Disease, Renhe Hospital, China Three Gorges University, Yichang 443001, China
  • Received:2010-11-29 Revised:1900-01-01 Online:2011-07-12 Published:2011-07-12

Abstract:

Objective To explore the influence of hemodialysis (HD) on the expression of inflammation marker lipoprotein-associated phospholipase A2 (LpPLA2) in end stage renal disease (ESRD) patients, we evaluated their changes in LpPLA2 activity and C-reactive protein (CRP) concentration before and after HD. Methods We observed 20 ESRD patients on HD, from whom 8ml peripheral blood were taken just before HD, after 2 h during HD, and immediately after HD. C-reactive protein was estimated by turbidometric assay, and LpPLA2 activity was measured by enzyme-linked immunosorbent assay (ELSA). Result In ESRD patients before HD, CRP concentration was higher than normal controls (P<0.01), but LpPLA2 activity was indifferent from the controls (P>0.05). In ESRD patients after a HD session, CRP concentration did not change significantly (P>0.05), as compared to that before HD and after 2h during HD. However, LpPLA2 activity increased greatly after 2h during HD and after a HD session (P<0.01), as compared to that before HD. Conclusion Hemodialysis can induce microinflammation in ESRD patients. This pro-inflammatory state may be introduced partially by the increase of LpPLA2 activity.

Key words: inflammation, lipoprotein-associated phospholipase A2